This breast cancer stem cell (BCSC) subpopulation features the expression of stem cell markers such as CD24low/CD44High, aldehyde dehydrogenases (ALDH) [2, 28] and largely contributes to tumor propagation, drug resistance and tumor relapse [29]. This evidence concerns the gene LDHA and breast cancer.